Lonafarnib: First Approval
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical)
Link
http://link.springer.com/content/pdf/10.1007/s40265-020-01464-z.pdf
Reference21 articles.
1. Guilbert SM, Cardoso D, Lévy N, et al. Hutchinson-Gilford progeria syndrome: rejuvenating old drugs to fight accelerated ageing. Methods. 2020. https://doi.org/10.1016/j.ymeth.2020.04.005
2. Harhouri K, Frankel D, Bartoli C, et al. An overview of treatment strategies for Hutchinson-Gilford progeria syndrome. Nucleus. 2018;9(1):246–57.
3. Li Y, Zhou G, Bruno IG, et al. Transient introduction of human telomerase mRNA improves hallmarks of progeria cells. Aging Cell. 2019;18(4):e12979.
4. Rampogu S, Baek A, Son M, et al. Discovery of lonafarnib-like compounds: pharmacophore modeling and molecular dynamics studies. ACS Omega. 2020;5(4):1773–81.
5. Capell BC, Erdos MR, Madigan JP, et al. Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci USA. 2005;102(36):12879–84.
Cited by 80 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Protein isoform-centric therapeutics: expanding targets and increasing specificity;Nature Reviews Drug Discovery;2024-09-04
2. Inflammation and Fibrosis in Progeria: Organ-Specific Responses in an HGPS Mouse Model;International Journal of Molecular Sciences;2024-08-28
3. The NLRP3 inhibitor Dapansutrile improves the therapeutic action of lonafarnib on progeroid mice;Aging Cell;2024-08-27
4. ThermoTargetMiner as a proteome integral solubility alteration target database for prospective drugs against lung cancer;2024-08-06
5. An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023);Journal of Medicinal Chemistry;2024-07-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3